《大行報告》里昂下調中建材(03323.HK)及海螺水泥(00914.HK)目標價 評級「跑輸大市」
里昂發表報告指,中資水泥股近期出現大幅回調,但認為長三角水泥降價並不意味全國性價格戰已經開始,相信是為整頓當地供應紀律,行業龍頭才於淡季反擊。
該行表示,由於長三角地區需求或於解除封鎖後恢復,預期水泥價格在淡季仍將受壓,但於第四季旺季恢復前的下行空間有限。
里昂下調對水泥股的盈利預測及目標價,以反映近期的降價。其中,華潤水泥(01313.HK)股份目標價由6.9元降至5.7元,評級「跑贏大市」;中國建材(03323.HK)目標價由9.8元降至8.4元,評級「跑輸大市」;海螺水泥(00914.HK)目標價由40元降至33.4元,評級同為「跑輸大市」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.